Clinical Trials
-
Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancer
Recruiting
-
AZD6244 in Treating Woman With Recurrent Low-Grade Ovarian Cancer
Recruiting
-
Carboplatin and Paclitaxel With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer
Recruiting
-
Collecting Tumor Samples From Patients With Gynecological Tumors
Recruiting
-
Combination Chemotherapy in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
Recruiting
-
Second Curettage in Treating Patients With Persistent Non-Metastatic Gestational Trophoblastic Tumor
Recruiting
-
Temsirolimus With or Without Megestrol and Tamoxifen in Treating Patients With Advanced, Persistent, or Recurrent Endometrial Cancer
Recruiting
-
Zoledronate or Observation in Maintaining Bone Mineral Density in Patients Who Are Undergoing Surgery to Remove Both Ovaries
Recruiting
-
A Study of Carboplatin and Gemcitabine Plus Bevacizumab in Patients With Ovary, Peritoneal, or Fallopian Tube Carcinoma (OCEANS)
Recruiting
-
Combination Study Of SB-485232 (Interleukin 18) And Doxil For Advanced Stage Epithelial Ovarian Cancer
Recruiting
-
Study of the Trifunctional Antibody Catumaxomab to Treat Recurrent Symptomatic Malignant Ascites
Recruiting
-
Cetuximab in Treating Patients With Persistent or Recurrent Cervical Cancer
No longer recruiting
-
Pazopanib Plus Lapatinib Compared to Lapatinib Alone and Pazopanib Alone In Subjects With Metastatic Cervical Cancer
No longer recruiting
-
Safety and Efficacy Clinical Study of SNS-595 in Patients With Platinum-Resistant Ovarian Cancer
No longer recruiting
-
Second-Line Therapy Study For Potentially Platinum-Sensitive Relapsed Ovarian Cancer
No longer recruiting
-
Trabectedin in Treating Patients With Advanced, Persistent, or Recurrent Leiomyosarcoma of the Uterus
Suspended
-
Clinical Trial for Ovarian Cancer (OvaRex®)
Terminated
-
Efficacy Multicentre Trial of ImmunoTherapy Vaccination With Abagovomab to Treat Ovarian Cancer Patients (MIMOSA)
No longer recruiting
-
Safety and Efficacy Study of the Trifunctional Antibody Catumaxomab to Treat Ovarian Cancer in Women After a Complete Response to Chemotherapy
Completed
Help